Background: Three-dimensional regenerative tissue with large bulk generally requires blood perfusion through a vascular network to maintain its viability, and one promising approach is induction of neovascular growth from the recipient bed into the tissue. To induce ingrowth of a vascular network, it is necessary to furnish the regenerative tissue with a scaffold structure for neovasculature and a delivery system for an angiogenic growth factor. As such a scaffold structure, the present study created novel hydrogel materials by chemically cross-linking alkali-treated collagen (AlCol) with trisuccinimidyl citrate (TSC). Materials and Methods: Many prototypes, consisting of several concentrations of TSC and AlCol, were implanted into the subfascial space of the rat rectus muscle, and 7 days later, the implanted materials were excised for histological analysis. Cross-sections were stained and neovascular development in the materials was evaluated by measuring vessel density, length and number of joints and branches. Results: Significant ingrowth of vascularized granulation was observed in some materials, which surpassed the angiogenic ability of Matrigel TM . Further, combination with basic fibroblast growth factor (bFGF) significantly increased the vascular formation in these gels. Conclusions: The TSC-AlCol gel functioned as a favorable scaffold for neovascular formation and also as a reservoir for controlled delivery of bFGF.
Introduction
R ecent advances in the fields of tissue engineering and stem cell biology have produced practical regenerative tissues, some of which have been applied in clinical settings for therapeutic purposes. 1, 2) However, at present, there are few regenerative products that completely reproduce or simulate the function of the original tissue or organ. One crucial reason for the unfavorable status is insufficient development of technology to construct the three-dimensional (3-D) structure of regenerative tissues.
3) If these 3-D technologies could be applied for tissue engineering, it would be possible to produce highlyorganized regenerative tissues with reasonable bulk, which would assure high performance of function and a long lifetime. In the construction of 3-D regenerative tissue, the most important step might be the formation of a vascular system in the tissue. 4) All tissues and organs require a supply of oxygen and nutrition and have to eliminate carbon dioxide and other metabolites. When the regenerative tissue is small enough, these processes can be accomplished by passive diffusion of environmental fluid, suggesting that blood perfusion is not always necessary in such a situation. In contrast, 3-D regenerative tissue with larger bulk requires blood perfusion through a vascular system to maintain the viability of the whole tissue, since the range of transportation by passive diffusion is limited to 100-200 μm at maximum. 5) Several approaches have been proposed to develop a vascular system in regenerative tissues, and one promising approach is induction of newly-formed vessels from the host vasculature by controlling vasculogenesis, angiogenesis or arteriogenesis. 4) Delivery of angiogenic growth factors or endothelial precursor cells potentially promotes these mechanisms of neovascularization, and this strategy has been applied for the treatment of vascular occlusive disease, such as ischemic heart disease and chronic limb ischemia. [6] [7] [8] However, to induce vessel formation in regenerative tissue, it is also important that the tissue is suitably furnished with a scaffold structure for newlyformed vessels, since it is essential for vessels in vivo to have a surrounding extracellular matrix (ECM) as a natural scaffold.
9) The vascular wall must be supported by ECM, and vascular cells receive several stimulants and signals via the matrix. 9) Matrigel TM , a preparation of basement membrane, is a well-known biomaterial that possibly serves as favorable scaffold for neovascularization, though it is difficult to utilize the material for clinical purposes, because it is extracted from mouse sarcoma. 10, 11) As a safe biomaterial to induce neovascular ingrowth, we previously developed physical gel matrix which was an ion complex of atelocollagen and alkali-treated collagen (AlCol) modified with trisuccinimidyl citrate (TSC). 12) In the present study, we created a chemical gel matrix for the same purpose. This hydrogel matrix was formed by chemically cross-linking AlCol with TSC, [13] [14] [15] and can be combined with a potent angiogenic growth factor, basic fibroblast growth factor (bFGF). Application of this biomaterial in regenerative tissue is expected to lead to development of a vascular network in the regenerative tissue after implantation in vivo.
Materials and Methods

Synthesis of hydrogel matrix from TSC and AlCol (TSC-AlCol gel)
TSC was prepared as described previously. 13) Briefly, citric acid was dissolved in tetrahydrofuran (THF), and then hydroxysuccimide (HOSu) and dicyclohexycarbodiimide (DCC) were added. This mixture was concentrated with rotary evaporation under reduced pressure, and recrystallized to yield TSC. For the synthesis of TSC-AlCol matrices, AlCol (type I, derived from pig skin, Nitta Gelatin Inc., Osaka, Japan) was dissolved in dimethylsulfoxide (DMSO) to obtain 7.5, 10, 15, 20 and 30% w/v AlCol solutions. Then, 50 μl TSC solution at a concentration of 1, 3, 6 or 10 mM was added to 200 μl of each AlCol diluent. The TSC-AlCol mixtures were poured into flat containers so as to be 1 mm thick and incubated for 24 h at 37°C to chemically crosslink AlCol with TSC, forming gel sheets (Fig. 1) . The gel sheets were subsequently immersed in excess 0.1 M phosphate buffer solution for 24 h at 37°C to remove DMSO, and disc-shaped gels with 6 mm diameter were cut out from the gel sheets (1 mm thick) for in vivo implantation. In the present study, we synthesized twenty kinds of TSC-AlCol gels for evaluation ( 
Animal model and implantation of TSC-AlCol matrices
Male Sprague-Dawley rats (3-4 months, Nisseizai, Tokyo, Japan) fed a normal diet were used in all experiments, and all protocols were conducted according to the Guide for Animal Experimentation of The University of Tokyo. Rats were anesthetized by intraperitoneal injection of sodium pentobarbital (50 mg/kg body wt). The rectus sheath was exposed through a middle incision of the abdomen, a longitudinal fasciotomy of the rectus sheath was carried out near the linea alba, and an appropriate space for implantation was prepared between the rectus sheath and the rectus abdominus muscle. After insertion of each TSC-AlCol gel disc (n = 6 for each gel disc) in the subfascial space, the rectus sheath was closed with polypropylene sutures. In another set of animals, a flat drop (30 μl, ca. 37 μg) of Matrigel TM (BD Biosciences, CA, USA) was implanted in the same manner (n = 6). The volume of 30 μl Matrigel TM was almost the same as that of the TSC-AlCol gel disc (6 mm diameter, 1 mm thick), and the flat drop of Matrigel TM was arranged in a similar shape to that of the TSC-AlCol gel disc before gelation.
At 7 days after implantation, these implants were excised with the surrounding rectus sheath and muscle tissue, fixed with 4% phosphate buffered paraformaldehyde (0.1 mol/l PO 4 buffer, pH 7.3) overnight, and embedded in paraffin.
Analysis of neovascular development in the TSC-AlCol gel
Each paraffin block was trimmed in order to expose the maximal transverse profile of the implanted materials, and 4-μm-thick cross-sections were cut. All sections were stained with hematoxylin & eosin. Then, other sets of cross-sections were stained for lectin to identify endothelial cells lining blood vessels.
16) The sections were first treated with 1% trypsin (Roche Applied Science) for 10 minutes, and then incubated with 3% hydrogen peroxide for 10 minutes. Subsequently, biotinylated lectin (L5391, Sigma, St. Louis, MO, USA) was applied at a 1:50 dilution for 2 hours at room temperature, and DAB treatment was carried out to develop brown color. Photomicrographs of cross-sections were taken with a digital microscope (BZ-9000, Keyence, Osaka, Japan) to analyze neovascular development in the implanted material. Since neovascularization in the material must progress from the tissue surrounding the material, analysis of cross sections was restricted to the peripheral region of each material, which was within 200 μm from the overall margin of the material profile, and the area of analysis was first measured with Image J software (National Institutes of Health, USA). Another reason for setting the analysis area within 200 μm from the margin was to eliminate the potential influence of a slight difference in implant shape and/or deformation. Then, using angiogenesis image analyzer software (KURABO, Kurabo, Osaka, Japan), the digital data of photomicrographs were binarized at a pre-set threshold, and the pixels that constituted blood vessels were counted in each binarized image. 17) The images were furthermore converted into line images by a thinning process, and the length of vessels and the number of vessel joints and branches were measured. Parameters for neovascular development were calculated as follows.
Vessel density (pixels/μm Analysis of the images was repeated twice in a blinded manner by a student helper, and the mean of the three values was used for statistical analysis.
Combination of bFGF with TSC-Alcol gel
To evaluate what amount of bFGF potentially combines with the TSC-AlCol gel, the gels were incubated with sufficient bFGF, and the amount of combined bFGF was measured. An excess (1 μg) of human recombinant bFGF (R&D Systems, MN, USA) was added to three kinds of TSC-AlCol gel discs (6 mm diameter and 1 mm thick, n = 4 each) whose formulation was 3, 6 or 10mM TSC and 15% AlCol (TSC[3, 6, 10]-AlCol 15). After 3 hours of incubation in a humid chamber at room temperature, the gel discs were washed three times with PBS to remove uncombined bFGF. Then, the bFGF-treated gel disc was homogenized and lysed in 100 μl high-salt buffer (50mM Tris [pH7.6], 1.5M NaCl, 1 mM PMSF, 10 μg/ml leupeptin), and the volume of the lysate was measured (V LYSATE ). The concentration of bFGF in the lysate (C bFGF ) was quantified by ELISA using a bFGF ELISA kit (R&D Systems) according to the manufacturer's instructions, and the amount of bFGF bound to each gel disc was calculated as V LYSATE × C bFGF .
Vascular development after implantation of bFGFtreated TSC-AlCol gels
Another series of TSC-AlCol gel discs (Fig. 1B) was incubated with 1 μg bFGF for 3 hours at room temperature, and washed three times with PBS. The bFGFtreated gel discs were implanted into the subfascial space of the rat abdomen. At 7 days after implantation, the implants were resected from the animals, and vascular development in the gels was evaluated in the same manner.
Statistical analysis
All data are presented as mean ± SE for each group. Student's t-test was used for comparison of each group. P values < 0.05 were considered statistically significant.
Results
Synthesis of TSC-AlCol gels
The gels were successfully synthesized in the presented formulations ( Table 1) . Reaction solvent, DMSO, was completely substituted by water. The color of the gels was water-clear, and the shape and hardness of the gels were stable in water for more than 1 month. As the concentration of TSC or AlCol decreased, the hardness of the synthesized gels became softer. In addition to the presented formulations, we tried to make TSC-AlCol mixtures whose concentration of AlCol was 5% or less; however, these mixtures did not gelate, irrespective of AlCol concentration.
Histological findings of excised implants
Histological analysis with hematoxylin & eosin staining showed the in vivo status of each material at 7 days after implantation, and also revealed how granulation development and inflammatory reactions were induced in and around the material on the same day. After implantation of TSC [1] -AlCol [7.5, 10, 15, 20, 30] and TSC [3] -AlCol [7.5, 10] gels, the structure of the gels completely disappeared, and no accumulation of inflammatory cells was detected around the implanted site. In contrast, other TSC-AlCol gels and Matrigel TM maintained their gel structure even at 7 days after implantation. Regarding granulation growth into the residual material, a certain amount of granulation tissue developed with inflammatory infiltration in TSC [3] (Fig. 2) .
Neovascular development after implantation of the TSC-AlCol gel
Histological staining for lectin successfully demonstrated the distribution of the vasculature in host tissue and also in the implanted materials. Vascular development into the implanted materials was detected in TSC [3] (Fig. 3) . (Fig. 4) .
Combination of bFGF with the TSC-AlCol gel
Vascular development after implantation of bFGFtreated TSC-AlCol gels
The combination of bFGF significantly increased vessel density and length in TSC [3] -AlCol [15] , TSC [6] AlCol [7.5, 10] and TSC [10] -AlCol [7.5] , as compared with those in untreated gels (Fig. 3A and 3B) . Further, the vessel joints and path showed significantly higher values in bFGF-treated gels than in untreated plain gels ( Fig. 3C and 3D ).
Discussion
A scaffold structure is essential for induction of neovascular growth into regenerative tissues, since neovasculature requires surrounding supportive tissues to maintain its luminal structure and biological performance. 9) In the present study, we developed a novel gel material that could function as a scaffold for neovascular growth. Many prototypes of hydrogel material were made by incorporating several concentrations of TSC and AlCol, and implanted into the subfascial space of the rat rectus muscle. Although some prototypes induced no growth of vasculature, gels with appropriate concentrations of TSC and AlCol markedly promoted neovascular formation in the gels at 7 days after implantation, which surpassed the angiogenic ability of Matrigel TM . There are some possible reasons why TSC-AlCol gels induced favorable growth of vascularized tissue into the material. One crucial reason might be that the TSCAlCol gel provided a suitable matrix microstructure as a platform for vessel formation. In vivo, vessels are naturally included in ECM, and ECM possesses the character of a hydrogel. Thus, it is not surprising that artificial hydrogel also reproduces a microstructure that mimics natural ECM.
18) Indeed, Zisch et al. synthesized an artificial hydrogel material based on polyethylene glycol (PEG) and synthetic peptides, and showed that vascularized tissue grew into the hydrogel material after implantation into the rat subcutis. 19) To realize such ECM-mimicking properties, however, the polymer network of the artificial hydrogel must have an adequate density. If the network of the polymer structure is too dense, vascular growth into the hydrogel could be physically blocked, and if the interstitial distance of the network is too large, the microstructure of the hydrogel would not sustain the surrounding wall of the neovasculature as a scaffold. In the present study, no growth of vasculature was observed in some prototypes, possibly indicating that their microstructure did not provide appropriate space for neovascular formation. Further, the combination of bFGF significantly promoted neovascular formation in some prototypes, in which vascular development was seemingly observed more in the hydrogel containing less AlCol. It possibly indicates that too dense TSC and AlCol would interfere with vascularization especially in the bFGF treated hydrogels because once bFGF was impregnated larger quantity of vascular development occurred and newly formed vessels themselves occupy certain extents of the space.
It is also important that the structure of the hydrogel contains cell adhesive sites to function as a scaffold for vascularized tissue. In vivo, ECM supports the vascular wall by anchoring vascular wall cells to matrix molecules. Attachment between vascular cells and surrounding ECM molecules is critical to establish the luminal structure of vessels and regulation of vessel growth. 9) In the mechanism of cell-ECM attachment, integrins play an important role as cell surface receptors. 18) Integrins are obligate heterodimers consisting of α and β subunits. In mammals, 19 α and 8 β subunits have been characterized, and more than 20 types of integrins with different combinations of α and β subunits have been identified. 20) Each integrin respectively binds with unique ECM components. As a matter of course, endothelial and other vascular cells also express several kinds of integrins on their cell membrane, 21) and some of these integrins can directly bind with collagen. 22) However, the predominant integrin-ligand in cell-ECM attachment is fibronectin, a high-molecular-weight glycoprotein. 23) Especially, fibronection is known to be a potent ligand of α v β 3 and α v β 5 , which are critical integrins in neovascularization and granulation formation. 21) Fibronection is abundantly contained in blood plasma in its soluble form, and it is also able to potently associate with collagen molecules. 23) Therefore, in the in vivo condition, which is fibronectinrich, integrins on the cell surface possibly bind with collagen molecules through the intermediary of sufficient fibronectin. These properties of collagen molecules suggest that TSC-AlCol gels possess adequate cell adhesive sites in their structure to function as a scaffold.
Another possible reason explaining the vascularization ability of the TSC-AlCol gel might be that the appropriate part of the gel was degraded according to neovascular growth into its inside. In this regard, it is critical that gel degradation should occur only in the direction of neovascular growth, and the other part of the gel structure must be preserved as a scaffold for newly formed vessels. For elongation and enlargement of vessels in vivo, vascular wall cells and infiltrating cells in ECM generally release a variety of proteases, such as matrix metalloproteinases (MMPs) and plasminogen activators (PAs), and promote the degradation of a surrounding ECM to ensure space for vessel growth. 24, 25) Therefore, the scaffold material for ingrowth of vascularized tissue must contain protease-cleavable sites and concomitantly possess stability against variable local situations except angiogenic proteases. Collagen molecules contain abundant MMPs-cleavable sites, 26) indicating that collagen is a potential material for induction of neovascularization. Indeed, a previous in vitro study showed that tube formation of endothelial cells was accelerated under culture in a gelated emulsion of collagen. 27) This evidence demonstrated that gelated collagen was successfully remodeled in vitro according to neovascularization, and also functioned as a scaffold for newly formed vessels. However, since collagen molecules are merely entangled in the emulsion form, a gelated emulsion of collagen might be dissolved by adding excessive fluid. If such a collagen material is implanted under physiological conditions in vivo, exudates accumulated around the implant consequentially dilute the collagen and then cause disintegration of its structure as a scaffold. Therefore, it is necessary to cross-link collagen molecules to stabilize the gel structure. Since the TSC-AlCol gel is a chemical gel in which collagen molecules are cross-linked by a citric acid derivative, TSC-AlCol gel enabled maintenance of a scaffold structure for vascular tissue, while only the gel part in the direction of vessel growth was digested by released proteases.
Further, the citric acid-based crosslinker, TSC also functions as a reservoir of bFGF. In general, angiogenic humoral factors play important roles in the induction of neovascularization, and previous studies have demonstrated several growth factors and cytokines to be angiogenic factors. 5) Each angiogenic factor possesses specific functions that contribute to neovascularization, and appropriate combinations of these functions promote appropriate vessel formation according to situational demand. Indeed, there are three processes in the formation of new vessels; vasculogenesis, angiogenesis and arteriogenesis, and these processes are generally induced by distinctive combinations of angiogenic factors. 28) Vasculogenesis in the adult represents a process by which endothelial progenitor cells differentiate and replicate to form a primitive network of vasculature, and angiogenesis is the process of endothelial migration and replication resulting in the formation of a capillary network. In contrast, arteriogenesis refers to the maturation and enlargement processes of preexisting small vessels, which increases the conducting ability of the blood vessels. The proposed function of the TSC-AlCol gel is to promote neovascular ingrowth from the surrounding host vasculature, followed by construction of a mature network of blood perfusion in the area of existing gel. It is, therefore, desirable that the TSC-AlCol gel enables induction of the process of arteriogenesis in addition to angiogenesis and/ or vasculogenesis. Since bFGF is known to induce angiogenesis and arteriogenesis, 6, 28) it is an ideal angiogenic factor for increasing the effect of vascular development in the TSC-AlCol gel. Further, it might be important that bFGF associated with the TSC-AlCol gel. When bFGF solution is added to the TSC-AlCol gel, bFGF molecules might permeate through the matrix structure of the TSCAlCol gel and then bind to the TSC part with ionic bonds, because bFGF is positively charged and TSC is negatively charged. 13) Therefore, there is a reserve of bFGF inside the TSC-AlCol gel, which stimulates the vessels that have grown into the gel, accelerating vascular development inside the gel. The present study indeed revealed that combination with bFGF significantly increased vascular formation in the TSC-AlCol gel. Further, measurement of bFGF level also showed that the concentration of combined bFGF in the TSC-AlCol gel was reasonable for proliferation of ordinary cells, though it might be necessary to clarify the relation between TSC concentration and combined bFGF level. 29) If the TSCAlCol gel is unable to bind with bFGF, bFGF in the gel might spread to the outside after implantation, and neovascularization might be induced only around the gel.
In summary, we created novel hydrogel materials by incorporating several concentrations of TSC and AlCol, and an in vivo study using a rat model showed that some of these materials had induced marked growth of vasculature-rich tissue into the inside of the materials at 7 days after implantation. Further, the ability of vascular ingrowth was significantly enhanced by combining bFGF with the materials. These findings suggest that the hydrogel materials functioned as a favorable scaffold for neovascular formation and also as a reservoir for controlled delivery of bFGF.
